Pacific Biosciences of California Inc (NASDAQ:PACB)
| 24.40 Delayed Data As of Oct 15 |  -0.15 / -0.61%Today’s Change | 11.22 Today|||52-Week Range 53.69 | -5.94% Year-to-Date |
Latest PACB News | Press Releases
| Green Alpha Advisors, LLC Buys Rapid7 Inc, Caribou Biosciences Inc, Seagate Technology Holdings ... Oct 12 / GuruFocus News - Paid Partner Content | Bull of the Day: Mesa Laboratories (MLAB) Oct 08 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 24.55 |
| Today’s open | 25.06 |
| Day’s range | 24.12 - 25.07 |
| Volume | 82,567 |
| Average volume (3 months) | 1,942,545 |
| Market cap | $4.9B |
Data as of 4:33pm ET, 10/15/2021
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -771.76% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | -13.20% |
| P/E ratio | NM |
| Price/Sales | 57.53 |
| Price/Book | 13.98 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BIOBBio Rad Laboratories... | +66.37 | +8.99% |
| DHRPRADanaher Corp | +5.37 | +0.27% |
| --Fluidigm Corp | +0.15 | +2.89% |
| FLDMFluidigm Corp | +0.16 | +3.08% |
Data as of 4:00pm ET, 10/15/2021
Financials
| Next reporting date | November 4, 2021 |
| EPS forecast (this quarter) | -$0.22 |
| Annual revenue (last year) | $78.9M |
| Annual profit (last year) | $29.4M |
| Net profit margin | 37.27% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Menlo Park, California |
Forecasts
